A New Jersey federal judge agreed to modify a prior ruling so a settlement resolving Teva Pharmaceutical Industries Ltd.’s infringement suit over Cipla Ltd.’s generic version of its Qvar asthma ...

In 1978, Cipla started manufacturing of Metered-Dose Inhaler (MDI). 1984 was the year when the company name was changed from The Chemical, Industrial & Pharmaceutical Laboratories to Cipla Limited.

Cipla Ltd is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and Active ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Cipla Q3 Profit Surges 49% to Rs 1,571 Crore Cipla's net profit for Q3 FY25 jumped 49% to Rs 1,571 crore, driven by growth across markets. Revenue rose to Rs 7,073 crore. Read more. Jan 28, 2025 16:23 ...

Cipla is currently trading at Rs 1470.55, reflecting a notable increase of 2.35% today, with 1-day returns at 2.03%. Cipla is currently valued at Rs 1466.00, marking a 2.04% rise today. The one-year ...

Cipla's stock is priced at Rs 1472.4, reflecting a slight uptick of 0.07% today, with a six-month return of 3.38%. Cipla is currently trading at Rs 1469.15, showing a slight decline of 0.16% today, ...

A young Wisconsin man died from an asthma attack after the price of his inhaler skyrocketed nearly $500, according to a lawsuit filed by his family. Cole Schmidtknecht, 22, suffered from asthma ...

Cipla reported a net profit of ₹1,303 crore, marking a 15% increase compared to the same period last year.